AgencySpy LostRemote TVNewser TVSpy FishbowlNY FishbowlDC SocialTimes AllFacebook GalleyCat UnBeige

Botox Maker Settles Charges for $600 Million

botox.jpg Allergan, the makers of Botox, have agreed to pay a $600 million settlement for charges that the company promoted the off-label use of the drug. According to the complaint, Allergan had a marketing program in place that would include “kickbacks” to doctors for prescribing Botox for things that it hasn’t been approved for, like pain treatment. The FDA is considering approval for Botox’s use in treating chronic migraines.

Allergan spokeswoman Caroline Van Hove denied kickback and fraud allegations in an emailed statement to the New York Times. The company issued a statement yesterday, saying that it plead guilty to one misdemeanor “misbranding” charge and agreed to pay $225 million to resolve civil claims.

“This is part of a departmentwide and administrationwide effort to really crack down on health care fraud,” Tony West, assistant attorney general for the civil division of the Justice Department, told the New York Times.

[Image via BioJobBlog]

Mediabistro Course

Applied Web Analytics

Applied Web AnalyticsStarting November 24, learn how to use metrics to drive your business goals! In this course, you'll learn how to set goals and produce results based on data, identify and track the KPIs for your website, and integrate your analytic efforts into your overall marketing strategy. Register now!